Intuition vs. Deliberation in Medical Decision Making
| Status: | Unknown status |
|---|---|
| Healthy: | No |
| Age Range: | 60 - Any |
| Updated: | 11/19/2017 |
| Start Date: | June 2015 |
| End Date: | June 2016 |
| Contact: | Emily B Rubin, MD |
| Email: | emily.rubin2@uphs.upenn.edu |
| Phone: | 617-797-0661 |
Intuition Versus Deliberation in Decisions About Life-Sustaining Medical Therapies
The purpose of this study is to determine whether there are systematic differences between
the decisions patients make intuitively versus deliberatively about life-sustaining medical
therapies.
The targeted population is inpatients at the Hospital of the University of Pennsylvania with
serious medical problems. The study will involve facilitated interviews with patients using a
survey instrument developed in Qualtrics.
the decisions patients make intuitively versus deliberatively about life-sustaining medical
therapies.
The targeted population is inpatients at the Hospital of the University of Pennsylvania with
serious medical problems. The study will involve facilitated interviews with patients using a
survey instrument developed in Qualtrics.
Inclusion Criteria:
1. Age 60 and older
2. Currently an inpatient at Hospital of the University of Pennsylvania
3. Speaks and reads fluently in English
4. Has one of the following medical conditions:
- Chronic obstructive pulmonary disease with at least severe airflow obstruction on
most recent spirometry and/or eligible for long-term oxygen therapy
- Incurable interstitial lung disease with at least severe restriction on most
recent pulmonary function tests and/or eligible for long-term oxygen therapy
- Congestive heart failure with NYHA Class III or higher and current
hospitalization related to heart failure
- Acute myeloid leukemia
- Stage IV lymphoma
- Stage IIIB or Stage IV non-small cell lung cancer, cholangiocarcinoma, renal cell
carcinoma, breast cancer, uterine cancer, cervical cancer, ovarian cancer,
colorectal cancer, gastric cancer, pancreatic cancer, prostate cancer, urothelial
cancer
- Stage C or D hepatocellular carcinoma
- Mesothelioma or any malignancy metastatic to the pleura
5. Stable vital signs
Exclusion Criteria:
1. Notation of code status limitation in electronic medical record
2. Cognitive impairment to the point unable to give informed consent
3. History of feeding tube placement
4. Severe pain or shortness of breath
We found this trial at
1
site
3400 Spruce St
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-4000
Principal Investigator: Scott D Halpern, MD, PhD
Phone: 215-573-9461
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
Click here to add this to my saved trials
